Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

510.68
-8.0800-1.56%
Post-market: 510.680.00000.00%19:41 EDT
Volume:487.19K
Turnover:249.84M
Market Cap:11.71B
PE:-39.74
High:523.34
Open:515.70
Low:498.03
Close:518.76
52wk High:615.00
52wk Low:265.00
Shares:22.94M
Float Shares:11.00M
Volume Ratio:0.90
T/O Rate:4.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8501
EPS(LYR):-12.8501
ROE:-42.49%
ROA:-16.30%
PB:19.44
PE(LYR):-39.74

Loading ...

Madrigal Builds Commercial Bench With Equity Grants Around Rezdiffra Growth Story

Simply Wall St.
·
Feb 02

Madrigal Pharmaceuticals Inc - and Roche Enter Into First Amendment to Agreement - SEC Filing

THOMSON REUTERS
·
Jan 31

Madrigal Pharmaceuticals Inc - Co Gains Control Over Rezdiffra Patent Term Adjustments - SEC Filing

THOMSON REUTERS
·
Jan 31

Madrigal Pharmaceuticals Gains Patent Control for Rezdiffra in Amended Roche Agreement

Reuters
·
Jan 31

Rezdiffra Sales Milestone and Pfizer DGAT-2 Deal Might Change The Case For Investing In Madrigal Pharmaceuticals (MDGL)

Simply Wall St.
·
Jan 29

Biotech Inventiva's 50% surge shows investor optimism over liver disease drug

Reuters
·
Jan 28

Madrigal Pharmaceuticals Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

Madrigal Pharmaceuticals initiated with an Overweight at Barclays

TIPRANKS
·
Jan 28

Madrigal Pharmaceuticals Lobbying And Insider Sales Put Valuation In Focus

Simply Wall St.
·
Jan 27

Can Trump and Big Pharma Get the World to Pay More for Drugs? -- Heard on the Street -- WSJ

Dow Jones
·
Jan 25

BRIEF-Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jan 23

Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer License For Ervogastat In MASH Therapy Combinations

Simply Wall St.
·
Jan 23

Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jan 22

U.S. RESEARCH ROUNDUP-Datadog, IBM, Netflix

Reuters
·
Jan 21

Top Madrigal Pharmaceuticals Insiders Quietly Cash In On Shares

TIPRANKS
·
Jan 21

Madrigal Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Rita Thakkar

Reuters
·
Jan 21

Madrigal Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Jan 20

Madrigal Pharmaceuticals price target raised to $745 from $527 at Citizens

TIPRANKS
·
Jan 20

Assessing Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer Partnership In Metabolic Liver Disease

Simply Wall St.
·
Jan 16

Director Paul A. Friedman Reports Disposal of Madrigal Pharmaceuticals Inc. Common Shares

Reuters
·
Jan 14